![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Kristen Marie Pettit, MD
AML Specialist
Specialities: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelofibrosis
Spoken languages: English
%20(1)-min_4771cbc6-89dc-42c9-a75f-98bd890b2167.jpg?alt=media&token=4e0dd707-a7bd-4c96-bc35-09f7b6607c87)
Clinical Expertise
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
About
Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia.
Location
Michigan State University Breslin Cancer Center: 401 W Greenlawn Ave, Lansing, MI 48910, USA
Get the latest thought leadership on your Myeloproliferative Neoplasm delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811